Navina co-founders Perera (right) and Ronen Lavi Photo David Garb, courtesy of Grove Ventures
Navina, an Israeli medtech startup that offers a clinical platform for primary care, has successfully closed a $55 million Series C funding round, bringing its total funding to $100 million. The round was led by Growth Equity at Goldman Sachs Alternatives, with continued support from Vertex Ventures Israel, Grove Ventures, and ALIVE.
This strategic investment will accelerate Navina’s expansion across the U.S. healthcare market, enhance its proprietary AI technology, and improve patient outcomes by integrating proactive clinical intelligence into every outpatient interaction.
Navina’s cutting-edge AI solutions empower healthcare providers with actionable insights, streamlining patient care management and enhancing decision-making for better health outcomes.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.
“This investment is a powerful validation of Navina’s vision to improve patient outcomes and healthcare economics by breaking down data barriers with AI,” said Ronen Lavi, co-founder and CEO of Navina. “We’re thrilled to partner with a best-in-class firm like Goldman Sachs, whose market leadership will be instrumental as we enter this pivotal growth phase and expand our market reach. With this additional capital, we will continue to accelerate AI innovation and revolutionize healthcare by making every patient interaction more empathic, personalized, and proactive.”
Navina explains that primary care physicians are overwhelmed by catastrophically complex and irregularly structured patient data. These deficiencies often result in missed diagnoses, provider and patient frustration, and economic loss. Navina uses medically-informed AI to restructure chaotic information into an “immediately clear, diagnostically-linked, actionable Patient Portrait. This data presentation gives physicians a radically reinvented view of their patient, resulting in better treatment and reduction of missed diagnoses.”
Navina says that its platform is able to put the “right information in front of physicians at the right time, to give them both a deep understanding of their patients at a glance and actionable insights at the point of care.
The shift towards value-based care in healthcare underscores the critical need for precise and timely clinical intelligence. Yet, clinicians often struggle with disparate data, cumbersome manual processes, and growing administrative demands, hindering their ability to provide proactive, preventive patient care and resulting in poorer outcomes and increased costs.
Navina addresses these challenges by providing clinicians and care teams with real-time, data-driven insights that improve both the quality of care and financial results. Navina’s AI copilot surfaces crucial clinical information to support effective decision-making at every stage of care – from administrative functions to the patient bedside – while significantly alleviating the administrative burden. Integrating smoothly into clinician workflows, Navina achieves a remarkable 86% weekly active usage rate and high clinician confidence in its AI recommendations in daily practice.
With this investment, Navina will advance its proprietary AI technology to ultimately become the leading source for unified patient data, enhancing efficiency and care quality across the entire healthcare spectrum, from payers to providers. The company plans to expand its platform’s capabilities to further automate and optimize workflows, ranging from proactive population health management to effective interventions during patient encounters.”
